ARCHIVES

Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Decision On New Division Two-Three Weeks Away: Upton

August 17, 1979

RAC Grumbles, Gives Healy Guidelines For Compassionate Use Of Gene Therapy

January 22, 1993

Tell NCI About science, Not Funding Mechanisms, Broder Says to Society

January 21, 1994

Organ Systems Support Contract To Cost More than OSCC Grant

September 30, 1988

HCT Survivors More Likely To Show Heart Disease Risk Factors

October 26, 2012

Dole to Press HCFA On Community DRG Exemptions, Calls For Meeting TO Assess Problems

March 16, 1984